Can 101 Therapeutics’ macrophage-targeting approach change the race for a Bundibugyo Ebola treatment?
101 Therapeutics has released new data on 101-PGC-005 for Bundibugyo Ebola disease. Discover what it could mean for outbreak response and drug development.
